Section 232 tariffs on medical devices are a blunt instrument for a precision industry

The Trump administration's focus on reducing foreign dependencies has led to Section 232 tariffs on medical devices, highlighting the administration's broader protectionist agenda. While tariffs aim to bolster domestic industries, this approach is criticized for its ineffectiveness in the precision-driven medical device sector. These tariffs may end up harming the very industry they intend to protect by making domestic products less competitive and driving up costs, which could ultimately benefit foreign manufacturers. This situation underscores the complexities of using tariffs as a broad economic tool.